Repository logo
 
Publication

Burden of Disease and Cost of Illness of Overweight and Obesity in Portugal

datacite.subject.fosCiências Médicas
datacite.subject.sdg10:Reduzir as Desigualdades
dc.contributor.authorBorges, Margarida
dc.contributor.authorSampaio, Filipa
dc.contributor.authorCosta, João
dc.contributor.authorFreitas, Paula
dc.contributor.authorMatias Dias, Carlos
dc.contributor.authorGaio, Vânia
dc.contributor.authorConde, Vasco
dc.contributor.authorFigueira, Débora
dc.contributor.authorPinheiro, Bernardete
dc.contributor.authorSilva Miguel, Luís
dc.date.accessioned2025-04-08T11:11:08Z
dc.date.available2025-04-08T11:11:08Z
dc.date.issued2024-11-24
dc.description.abstractIntroduction: The prevalence of overweight and obesity has increased in the last decades, posing significant health and economic impacts globally. These conditions are related to several non-communicable diseases, including cardiovascular disease, type II diabetes, and cancer. This study estimated the disease burden and healthcare costs associated with overweight and obesity in the adult population in mainland Portugal, in 2018. Method: Burden of disease was measured in disability-adjusted life years (DALYs) following Global Burden of Disease (GBD) methodology. DALYs were calculated as the sum of years of life lost (YLL) and years lived with disability (YLD). The analyses included morbidity, mortality, and related costs directly related to overweight and obesity, as well as the attributable morbidity, mortality, and related costs of 25 selected diseases related to obesity (DrO). A prevalence-based cost analysis was conducted a from the perspective of the public National Health Service, including costs related to inpatient, outpatient care, and pharmacological treatment. Results: In 2018, total DALY amounted to 260,943, with 75% due to premature death (196,438 YLL) and 25% due to disability (64,505 YLD). The economic burden of overweight and obesity was estimated at approximately EUR 1,148 million. Of these, approximately EUR 13.3 million (1%) were costs related to the treatment of obesity, and the remaining were costs of DrO attributed to overweight and obesity. Outpatient care corresponded to 43% of total costs, pharmacological treatment 38%, and inpatient care 19%. Cardiovascular and cerebrovascular diseases were the largest contributor to total costs (38%), followed by type II diabetes (34%). Conclusion: Overweight and obesity incur a large disease and economic burden to the public healthcare sector, representing approximately 0.6% of the country's gross domestic product and 5.8% of public health expenditures.por
dc.description.sponsorshipThis study was funded by Novo Nordisk Portugal, Lda.
dc.identifier.citationObes Facts . 2024 Nov 5:1-14. doi: 10.1159/000541781. Online ahead of print.
dc.identifier.doi10.1159/000541781
dc.identifier.issn1662-4025
dc.identifier.pmid39500293
dc.identifier.urihttp://hdl.handle.net/10400.18/10493
dc.language.isoeng
dc.peerreviewedyes
dc.publisherKarger Publishers
dc.relation.hasversionhttps://karger.com/ofa/article/doi/10.1159/000541781/915557/Burden-of-Disease-and-Cost-of-Illness-of
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectBurden of Disease
dc.subjectCost of Illness
dc.subjectDisability-adjusted Life Years
dc.subjectObesity
dc.subjectOverweight
dc.subjectPortugal
dc.subjectEstados de Saúde e de Doença
dc.titleBurden of Disease and Cost of Illness of Overweight and Obesity in Portugalpor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage14
oaire.citation.startPage1
oaire.citation.titleObesity Facts: The European Journal of Obesity
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameMatias Dias
person.familyNameGaio
person.givenNameCarlos
person.givenNameVânia
person.identifier.ciencia-id6311-6117-ADEB
person.identifier.ciencia-idA71A-17AF-30C7
person.identifier.orcid0000-0002-0206-5874
person.identifier.orcid0000-0001-7626-4991
person.identifier.ridI-6335-2012
person.identifier.scopus-author-id23103292400
person.identifier.scopus-author-id56080468200
relation.isAuthorOfPublicationfe9524e7-fc22-42f6-8eca-ab6a513ddd6b
relation.isAuthorOfPublication59791814-187c-4b34-b3a2-6ad67a213814
relation.isAuthorOfPublication.latestForDiscoveryfe9524e7-fc22-42f6-8eca-ab6a513ddd6b

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
24-Borges et al, 2024.pdf
Size:
379.42 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.03 KB
Format:
Item-specific license agreed upon to submission
Description: